your market intelligence analyst
Search Results
542 results
Your search is now limited to «Cancer Drugs» expert search.
Drugmaker recalls heartburn drug Zantac over cancer concerns.
More from Healthcare Policy:
The purpose of this guidance is to assist sponsors in the development of drugs, including biologics, for the treatment of patients who have bacillus Calmette-Guérin (BCG)-unresponsive nonmuscle invasive bladder cancer (NMIBC.
More from U.S. Food & Drug Administration - FDA - What's New: Drugs (FDA):
ENDPOINTS 10/18/2019 09:29
She’ll put that experience to use expanding the oncology pipeline at Novartis, where cancer drugs are a major focus.
More from ENDPOINTS:
Forbes 10/18/2019 08:41
J&J’s oncology drugs portfolio sales grew from $4.5 billion in 2014 to $9.8 billion in 2018.
More from Forbes: 10/18/2019 07:30
So, different methods have tried to select effective drug before chemotherapy.Drug sensitivity screening in vitro for different chemotherapy drugs was a promising method.
More from
Non-Small Cell Lung Cancer Drugs market manufacturers place orders when they receive work orders from Non-Small Cell Lung Cancer Drugs market operators such as commercial, military, and others.
More from Middle East North Africa Financial Network (MENAFN):
MedCity News 10/17/2019 15:23
Syros eyes strategic shift after failure of hitherto promising cancer drug.
More from MedCity News:
Healio News 10/17/2019 12:10
Fam-] trastuzumab deruxtecan has the potential to transform the treatment landscape for patients with HER2-positive metastatic breast cancer who have limited treatment options,” José Baselga, MD, PhD, executive vice president of research and development oncology at AstraZeneca, said in the release.
More from Healio News:
FierceBiotech 10/17/2019 11:45
Drug resistance is a big problem in cancer therapy and targeting cancer evolution will be a key part in solving this problem,” he said.
More from FierceBiotech:
Benzinga 10/17/2019 10:51
Despite recent improvements and approvals of medicines, a significant clinical need remains for patients with advanced HER2-positive metastatic breast cancer, according to AstraZeneca.
More from Benzinga:
ETHealthWorld (India) 10/17/2019 05:30
Glenmark Pharma gets USFDA nod for prostate cancer treatment drug, Health News, ET HealthWorld.
More from ETHealthWorld (India):
Pharmafile 10/17/2019 04:33
The Prescription Drug User Fee Fact (PDUFA) date for trastuzumab deruxtecan, an HER-2 targeting antibody drug conjugate and potential new medicines for the treatment of HER2-positive metastic breast cancer is set for the second quarter of 2020 ...
More from Pharmafile:
Xconomy 10/16/2019 12:15
Eli Lilly (NYSE: LLY) said Wednesday that patients treated with its drug candidate pegilodecakin, plus chemotherapy, did not live longer than patients treated with chemotherapy alone, falling short of the main goal of a Phase 3 study.
More from Xconomy:
BioPharma Dive 10/16/2019 11:21
The drug's failure to show a survival benefit in pancreatic cancer narrows those prospects, and puts greater importance on two Phase 2 lung cancer studies expected to read out results in early 2020.
More from BioPharma Dive:
Medical Xpress - Cancer News 10/16/2019 10:06
The important trial could lead to a much-needed new treatment for patients with alveolar soft part sarcoma (ASPS), which tends to affect younger adults and does not respond well to existing treatments.
More from Medical Xpress - Cancer News: 10/16/2019 07:28
As APOBEC3B is not an essential part of the body's immune response, its inhibition could support existing cancer therapies by stopping cancer cells developing resistance to the treatments.
More from

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications